Michael LaBarre
Chief Tech/Sci/R&D Officer chez HALOZYME THERAPEUTICS, INC.
Fortune : 7 M $ au 31/03/2024
Postes actifs de Michael LaBarre
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 | - |
| General Counsel | - | 01/01/2020 | |
| Corporate Officer/Principal | 16/06/2008 | 24/08/2015 |
Historique de carrière de Michael LaBarre
Anciens postes connus de Michael LaBarre
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2003 | 01/04/2006 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01/11/1995 | 01/12/2003 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - | - |
Formation de Michael LaBarre
| Stony Brook University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
- Bourse
- Insiders
- Michael LaBarre
- Expérience
